Slide

NEWS & PRESS


All News & Press

June 14, 2022

Corden Connect Interviews Managing Director Martin Walde of CordenPharma Lisbon

Edition 2 / June 2022
New Facility Acquisition Video Series > Part 2: Interview with Managing Director Martin Walde
of CordenPharma Lisbon
June 14, 2022

CordenPharma & Wacker Prepare for mRNA Vaccine Production

Edition 2 / June 2022
News > CordenPharma & Wacker Awarded Pandemic Preparedness Contract
June 14, 2022

Fribourg Site Inaugurates Newly-Expanded Drug Product Facility

Edition 2 / June 2022
Small Molecules Platform > CordenPharma Fribourg Inaugurates Expanded Drug Product Manufacturing Facility
June 8, 2022

World Pharma Today: Solid Dose Pharmaceuticals to Remain Strong

June 8, 2022
World Pharma Today Interview: Dr. Brittany Hayes talks trends & strategy of Oral Solid Dose (OSD) manufacturing.
June 1, 2022

Strategic Investment Increases xRNA-based LNP Formulation Services at Caponago Injectable Facility

June 1, 2022
Press Release > CordenPharma Invests in xRNA-based LNP Formulation Services at its Caponago Injectable Facility.
May 2, 2022

Astorg to Acquire Leading Pharmaceutical CDMO CordenPharma from ICIG

May 2, 2022
Press Release > Astorg to Acquire Leading Pharmaceutical CDMO CordenPharma from ICIG.
April 11, 2022

CordenPharma and WACKER To Produce mRNA Vaccines for Germany When Needed

April 11, 2022
Press Release > Wacker & CordenPharma win contract to be stand-by ready to produce mRNA vaccines for German government if needed.
March 14, 2022

CEO Discusses CDMO Capex Growth & Expansion in 2022

Edition 1 / March 2022
CEO Editorial > 2022 & Beyond: Resiliency, Expansion & Growth
March 14, 2022

Corden Connect Interviews New Managing Director Yvan Liard of CordenPharma Fribourg

Edition 1 / March 2022
New Facility Acquisition Video Series > Part 1: Interview with Managing Director Yvan Liard of CordenPharma Fribourg
March 14, 2022

Three New Drug Product Facilities Expand Small Molecules Platform

Edition 1 / March 2022
Small Molecules Platform > Three New Drug Product Facilities Expand & Augment Our Small Molecules Platform
March 14, 2022

LNP Formulation Process Capability Expansion in Caponago

Edition 1 / March 2022
Lipid & Injectable Platforms > New Lipid NanoParticle Formulation Capabilities Bring Flexible Drug Development Options
March 10, 2022

CordenPharma Donates to Support Disaster Relief Efforts in the Ukraine

March 10, 2022
CordenPharma donates a combined €100,000 to support disaster relief efforts in the Ukraine.
March 3, 2022

CEO Michael Quirmbach Talks Expanded Footprint, Green Chemistry & Growth

March 3, 2022
Global Business Reports Interview: CEO Michael Quirmbach Talks 2022 Expanded Footprint & Growth Strategy
March 1, 2022

CordenPharma Chenôve Increases Lipid Manufacturing Capacity to Support mRNA Vaccines

March 1, 2022
Press Release > CordenPharma Chenôve Increases Lipid Manufacturing Capacity to Support mRNA Vaccine Strategy.
January 26, 2022

CordenPharma Completes Acquisition of 3 Facilities from Vifor Pharma

February 1, 2022
Press Release > CordenPharma Completes Acquisition of 3 Facilities from Vifor Pharma